From: Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Marker expression | Patients (n) | Patients (%) | Median survival (months) | 5-Year survival (%) | P |
---|---|---|---|---|---|
CD 57 | Â | Â | Â | Â | Â |
 Low | 93 | 37 | 54 | 49 | 0.617 |
 High | 135 | 54 | 49 | 48 |  |
 Missing | 21 | 8 |  |  |  |
CD 68 | Â | Â | Â | Â | Â |
 Low | 57 | 23 | 91 | 52 | 0.270 |
 High | 172 | 69 | 45 | 47 |  |
 Missing | 20 | 8 |  |  |  |
M-CSF | Â | Â | Â | Â | Â |
 Low | 56 | 22 | NR | 59 | 0.034 |
 High | 169 | 68 | 38 | 44 |  |
 Missing | 24 | 10 |  |  |  |
CSF-1R | Â | Â | Â | Â | Â |
 Low | 38 | 15 | 41 | 44 | 0.832 |
 High | 191 | 77 | 38 | 46 |  |
 Missing | 20 | 8 |  |  |  |
Ki67 | Â | Â | Â | Â | Â |
 Low | 31 | 12 | NR | 63 | <0.001 |
 Medium | 63 | 25 | NR | 59 |  |
 High | 139 | 56 | 24 | 37 |  |
 Missing | 16 | 6 |  |  |  |
TGF-beta | Â | Â | Â | Â | Â |
 Low | 117 | 47 | 99 | 53 | 0.003 |
 High | 122 | 49 | 29 | 37 |  |
 Missing | 10 | 4 |  |  |  |
M-CSF and TGF-beta | Â | Â | Â | Â | Â |
 Low | 119 | 48 | 91 | 53 | 0.004 |
 High | 101 | 41 | 29 | 38 |  |
 Missing | 29 | 12 |  |  |  |